Tru-D is on a Mission to Eradicate C. diff and other Hospital-acquired Infections

Tru-D SmartUVC uses chemical-free, environmentally-friendly UVC energy to render C. diff and other deadly pathogens harmless and unable to replicate. UVC light has been shown to reduce the spread of C. diff in hospitals and health care facilities, providing a cleaner, safer environment. Validated by more than 20 independent studies as well as the only randomized clinical trial on UVC disinfection, Tru-D is on a mission to eradicate C. diff and other hospital-acquired infections that adversely affect patient outcomes.

C. diff Statistics

500,000 cases per year
$15,000 associated deaths
$15,275 average cost to a hospital

C. diff Statistics

C. diff is one of the most deadly and hard-to-kill superbugs that is most commonly found in health care facilities. While it can be resistant to antibiotics, it cannot withstand UVC energy.

Does Tru-D Kill C. diff?

12% C. diff Reduction at Chesapeake Regional
HAIs eliminated at Yavapai Regional

Individual hospital results vary. The BETR-D randomized clinical trial showed an 11% reduction in C. diff rates hospital-wide when paired with 93% compliance with standard disinfection protocols.

BETR-D Randomized Clinical Trial

When the BETR-D study analysis is expanded to all patients who entered the hospital, researchers saw a statistically significant reduction in C. diff rates hospital-wide, leading to a safer environment for everyone.

Individual hospital results vary based on adherence to standard disinfection protocol.

BETR-D Randomized Clinical Trial

When the BETR-D study analysis is expanded to all patients who entered the hospital, researchers saw a statistically significant 11% reduction in C. diff rates hospital-wide.

C. Diff Foundation

Tru-D Proudly Supports the C. Diff Foundation

C. Diff Foundation

The C. Diff Foundation is dedicated to supporting public health through education and advocating for C. diff prevention, treatment, environmental safety and support worldwide.

Tru-D is a proud sponsor of the C. Diff Foundation. Visit cdifffoundation.org to learn more about their organization and how it impacts C. diff patients.

As part of the secondary analysis of the BETR-D study, the researchers showed that with an enhanced terminal room UVC disinfection program in place, the entire hospital environment is safer. This occurred with 93% compliance of disinfection protocols. Regardless of whether the room was previously occupied with a patient who had an MDRO (multidrug-resistant organism), or whether or not they had been previously colonized, if you add a structured, targeted UVC disinfection program to your cleaning protocols, your hospital is likely to have fewer cases of C. diff and VRE.